ePrints

A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours

Lookup NU author(s): Professor Ruth Plummer, Professor Steve Wedge, Professor Gareth Veal

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Plummer R, Halford S, Jones P, Wedge S, Hirschberg S, Veal G, Payne G, Chenard-Poirier M, Keun H, Banerji U

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: International Congress on Targeted Anticancer Therapies (TAT) 2018

Year of Conference: 2018

Pages: iii9-iii9

Print publication date: 01/03/2018

Acceptance date: 02/04/2016

ISSN: 0923-7534

Publisher: Elsevier BV

URL: https://doi.org/10.1093/annonc/mdy048.008

DOI: 10.1093/annonc/mdy048.008

Series Title: Annals of Oncology

Share